ClinVar Miner

Submissions for variant NM_000257.4(MYH7):c.5740G>A (p.Glu1914Lys)

dbSNP: rs397516254
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Cardiomyopathy Variant Curation Expert Panel RCV000035983 SCV000564463 likely pathogenic Primary dilated cardiomyopathy 2021-03-22 reviewed by expert panel curation The c.5740G>A (p.Glu1914Lys) variant in MYH7 has been reported in at least 6 individuals with complex cardiomyopathy presentations, including predominantly dilated cardiomyopathy, features of LVNC, and restrictive physiology with early-onset in multiple instances (Lakdawala 2012 PMID: 22464770; Pugh 2014 PMID: 24503780; Lamont 2015 PMID: 20301606; Walsh 2017 PMID: 27532257; Wang 2017 PMID: 28855170; Miura 2019 PMID: 30996762). This variant segregated with disease in 2 affected siblings from 1 family (Miura 2019 PMID: 30996762); however this data is currently insufficient to apply PP1. This variant has been confirmed de novo occurrence in 2 of the above reported individuals with additional features of myopathy (PS2; Lamont 2014 PMID24664454). This variant was absent from large population studies (PM2;, v2.1.1). Computational prediction tools and conservation analysis suggest that this variant may impact the protein (PP3). In summary, this variant meets criteria to be classified as likely pathogenic for dilated cardiomyopathy in an autosomal dominant manner. MYH7-specific ACMG/AMP criteria applied (Kelly 2018 PMID:29300372): PS4_Moderate; PS2; PM2; PP3
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000035983 SCV000059635 pathogenic Primary dilated cardiomyopathy 2016-01-29 criteria provided, single submitter clinical testing The p.Glu1914Lys variant in MYH7 has been previously identified in 3 individuals with childhood onset of DCM and was de novo in two of them with parental relati onships confirmed (Lakdawala 2012, Lamont 2014, Pugh 2014). It was absent from l arge population studies. This variant was predicted to be pathogenic using a com putational tool clinically validated by our laboratory. This tool's pathogenic p rediction is estimated to be correct 94% of the time (Jordan 2011). In summary, this variant meets our criteria to be classified as pathogenic.
Baylor Genetics RCV001329735 SCV001521255 pathogenic Dilated cardiomyopathy 1S 2020-02-19 criteria provided, single submitter clinical testing This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868].
CeGaT Center for Human Genetics Tuebingen RCV002510774 SCV002822117 pathogenic not provided 2022-10-01 criteria provided, single submitter clinical testing MYH7: PS4, PM1, PM2, PP2, PP3
Invitae RCV002513365 SCV003442268 pathogenic Hypertrophic cardiomyopathy 2023-05-03 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MYH7 protein function. ClinVar contains an entry for this variant (Variation ID: 43088). This missense change has been observed in individual(s) with dilated cardiomyopathy, hypertrophic cardiomyopathy, and/or additional features of skeletal myopathy (PMID: 22464770, 24664454, 27532257, 28855170, 30996762). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 1914 of the MYH7 protein (p.Glu1914Lys).
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV003149624 SCV003838096 likely pathogenic Cardiomyopathy 2022-03-18 criteria provided, single submitter clinical testing
Neurogenetics Laboratory, Royal Perth Hospital RCV000132760 SCV000119911 pathogenic Dilated cardiomyopathy 1S; MYH7-related skeletal myopathy 2013-01-01 no assertion criteria provided clinical testing
GeneReviews RCV000192205 SCV000223112 not provided MYH7-related skeletal myopathy no assertion provided literature only Associated with cardiac transplant at age 3 and 3.5 yrs

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.